Facile syntheses of functionalized toll-like receptor 7 agonists

被引：5

作者：

Akinbobuyi, Babatope ^{[1
]}

Byrd, Matthew R. ^{[1
]}

Chang, Charles A. ^{[2
]}

Nguyen, Mysa ^{[1
]}

Seifert, Zacharie J. ^{[1
]}

Flamar, Anne-Laure ^{[3
]}

Zurawski, Gerard ^{[2
,3
]}

Upchurch, Katherine C. ^{[2
]}

Oh, SangKon ^{[2
,3
]}

Dempsey, Stephen H. ^{[4
]}

Enke, Thomas J. ^{[4
]}

Le, John ^{[4
]}

Winstead, Hunter J. ^{[4
]}

Boquin, Jose R. ^{[4
]}

Kane, Robert R. ^{[1
,2
,3
]}

机构：

[1] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA

[2] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA

[3] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX 75204 USA

[4] Augustana Coll, Dept Chem, Rock Isl, IL 61201 USA

来源：

TETRAHEDRON LETTERS | 2015年 / 56卷 / 02期

关键词：

Toll-like receptor; Adenine derivatives; Vaccines; Immune activation; POTENT INTERFERON-INDUCERS; 8-OXOADENINE DERIVATIVES; BIOLOGICAL EVALUATION; INNATE IMMUNITY; IMIDAZOQUINOLINES; 8-HYDROXYADENINES; 9-BENZYLADENINES; RECOGNITION; DISCOVERY; VACCINES;

D O I：

10.1016/j.tetlet.2014.11.126

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Protein conjugates of toll-like receptor 7 agonists have been shown to elicit powerful immune responses. In order to facilitate our studies in this area our group has developed efficient syntheses for a number of functionalized derivatives that retain immune stimulatory activity. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：458 / 460

页数：3

共 50 条

[21] Toll-like receptor agonists in adjuvant immunotherapy for cancer
Farkas, A.
Urosevic, M.
Dummer, R.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S21 - S21
[22] Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice
Gao, Wenyan
Sun, Xiaodan
Li, Danni
Sun, Lin
He, Yang
Wei, Huanping
Jin, Feng
Cao, Yaming
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
[23] Toll-Like Receptor Agonists as Adjuvants for HIV Vaccines
Stevceva, L.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5079 - 5082
[24] Toll-like receptor agonists as cancer vaccine adjuvants
Jeon, Donghwan
Hill, Ethan
Mcneel, Douglas G.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[25] Toll-Like Receptor Agonists for Treatment of Viral Infections
Abdel-Magid, Ahmed F.
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (02): : 153 - 154
[26] Plant lectins are novel Toll-like receptor agonists
Unitt, John
Hornigold, David
BIOCHEMICAL PHARMACOLOGY, 2011, 81 (11) : 1324 - 1328
[27] Toll-like receptor 9 agonists as cancer therapeutics
Holtick, Udo
Scheulen, Max E.
von Bergwelt-Baildon, Michael S.
Weihrauch, Martin R.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372
[28] A protective role for toll-like receptor 3 but not toll-like receptor 7 in intimal hyperplasia
Cole, J.
Navin, T.
Cross, A.
Goddard, M.
Alexopoulou, L.
Ucci, S.
Sivagurunathan, B.
Davies, A.
Flavell, R.
Feldmann, M.
Monaco, C.
IMMUNOLOGY, 2011, 135 : 106 - 106
[29] Toll-Like Receptor Agonists: Not Just for Vaccines Anymore
Tomai, Mark
BIOPHARM INTERNATIONAL, 2011, 24 (01) : S15 - S16
[30] MICROGLIAL RESPONSES TO ENDOGENOUS TOLL-LIKE RECEPTOR AGONISTS
Hanisch, U. K.
Moeller, T.
GLIA, 2009, 57 (13) : S6 - S6

← 1 2 3 4 5 →